Advertisement
Australia markets closed
  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     
  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     
  • AUD/USD

    0.6545
    +0.0021 (+0.33%)
     
  • OIL

    83.95
    +0.38 (+0.45%)
     
  • GOLD

    2,353.00
    +10.50 (+0.45%)
     
  • Bitcoin AUD

    98,322.94
    +1,274.14 (+1.31%)
     
  • CMC Crypto 200

    1,338.07
    -58.47 (-4.19%)
     
  • AUD/EUR

    0.6111
    +0.0038 (+0.62%)
     
  • AUD/NZD

    1.0988
    +0.0031 (+0.28%)
     
  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     
  • NASDAQ

    17,686.54
    +256.04 (+1.47%)
     
  • FTSE

    8,132.25
    +53.39 (+0.66%)
     
  • Dow Jones

    38,289.42
    +203.62 (+0.53%)
     
  • DAX

    18,158.66
    +241.38 (+1.35%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

3 Beaten-Down Stocks That Could Soar This Year

3 Beaten-Down Stocks That Could Soar This Year

Here's why they picked CRISPR Therapeutics (NASDAQ: CRSP), Exelixis (NASDAQ: EXEL), and Intellia Therapeutics (NASDAQ: NTLA). Prosper Junior Bakiny (CRISPR Therapeutics): Unprofitable clinical-stage biotech companies got hammered last year. Gene-editing specialist CRISPR Therapeutics fits that description to a T, so it got dragged down along with the broader market.